Chronic obstructive pulmonary disease is a disease in which the airways are partially or completely blocked, making breathing difficult. COPD can be caused by a long-term inflammatory process caused by smoking, severe environmental factors, and the disease can also be the result of congenital lung defects. Manifested by shortness of breath, frequent wet cough.
One of the groups of drugs for the treatment of chronic obstructive pulmonary diseases are drugs based on beclomethasone dipropionate (in Russia, a synonym for Nasobek). Beta2-adrenergic receptor blockers, drugs from the secretagogue group. Has an anti-inflammatory effect. Switching beta 2-agonists from non-selective (Salbutamol (When choosing drugs for replacement, we recommend focusing on commercial names)) to selective ones increases effectiveness